阿茲海默症藥物市場：按藥物類別、給藥途徑、分銷管道和地區分類

預計2024年全球阿茲海默症治療市場規模將達51億美元，預計2031年將達101.1億美元，2024年至2031年複合年成長率為10.3%。

圖：2024 年阿茲海默症藥物市場佔有率（按地區分類）

阿茲海默症是一種進行性神經退化性疾病，會逐漸破壞記憶和認知能力。它是老年人失智症最常見的原因。全球阿茲海默症藥物市場的成長是由全球阿茲海默症率上升所推動的。根據世界衛生組織統計，全球約有 5,000 萬人患有失智症，每年新增近 1,000 萬例失智症。針對阿茲海默症潛在病理生理學的新型緩解疾病藥物的核准和上市正在增加，並可能在預測期內推動市場成長。

市場動態：

全球阿茲海默症藥物市場的成長是由老年人口的增加、阿茲海默症病率的增加、新型緩解疾病藥物的推出、醫療保健支出的增加以及人們對阿茲海默症的認知不斷提高推動的。然而，與藥物研發相關的高成本以及後期臨床試驗的失敗可能會阻礙市場成長。擁有大量老年人口的發展中地區提供了巨大的成長機會。此外，早期診斷的技術進步和闡明病理狀況的進展也可能提供新的商機。

本研究的主要特點

本報告對全球阿茲海默症藥物市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。

根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球阿茲海默症治療市場的主要企業進行了分析。

本研究涵蓋的主要企業包括艾伯維公司(AbbVie, Inc.)、梯瓦製藥有限公司(Teva Pharmaceuticals Ltd.)、衛材有限公司(Eisai Co., Ltd.)、楊森製藥公司(Johnson & Johnson )、諾華公司(Novartis AG)、Zydus Lifesciences Ltd (CADILA)、太陽製藥工業有限公司(Sun Pharmaceutical Industries Ltd.)。 Viatris Inc.、Lupin Ltd、Cipla Ltd.、Torrent Pharmaceuticals Ltd.、Unichem Laboratorys ltd、Lannett Inc.

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球阿茲海默症藥物市場報告針對該行業的各個相關人員相關者，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。

相關人員可以透過用於分析全球阿茲海默症藥物市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

• 研究目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球阿茲海默症藥物市場 - 冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章全球阿茲海默症藥物市場，依藥物類別，2019-2031

• 膽鹼酯酶抑制劑
• 多奈哌齊
• Rivastigmine
• Galantamine
• NMDA受體拮抗劑
• Memantine
• 聯合治療
• 多奈哌齊Memantine
• 管道藥品
• 阿杜卡單抗
• 樂卡奈單抗
• 多納單抗

第6章全球阿茲海默症藥物市場，依給藥途徑，2019-2031

• 口服
• 胃腸外的
• 其他

第7章全球阿茲海默症藥物市場，依分銷管道，2019-2031

• 醫院藥房
• 零售藥房
• 網路藥房

第8章全球阿茲海默症藥物市場（按地區），2019-2031

• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第9章 競爭格局

• 公司簡介
  • AbbVie, Inc.
  • Teva Pharmaceuticals Ltd.
  • Eisai Co., Ltd.
  • Janssen Pharmaceuticals, Inc.（Johnson &Johnson）
  • Novartis AG
  • Zydus Lifesciences Ltd（CADILA）
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd.
  • Viatris Inc.
  • Lupin Ltd
  • Cipla Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Unichem laboratories ltd
  • Lannett Inc.

第10章分析師建議

• 命運之輪
• 分析師觀點
• 一致的機會圖

第11章 參考文獻與調查方法

• 參考
• 調查方法

Global Alzheimer's drugs market is estimated to be valued at USD 5.10 Bn in 2024 and is expected to reach USD 10.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031.

Figure. Alzheimers Drugs Market Share (%), By Region 2024

Alzheimer's disease is a progressive neurodegenerative disease that slowly destroys memory and cognitive skills. It is the most common cause of dementia among older people. Global Alzheimer's drugs market growth is driven by rising prevalence of Alzheimer's disease worldwide. According to WHO, around 50 million people globally have dementia with nearly 10 million new cases every year. Rising approval and launch of novel disease modifying drugs that target the underlying pathophysiology of Alzheimer's can drive the market growth over the forecast period.

Market Dynamics:

Global Alzheimer's drugs market growth is driven by rising geriatric population, increasing prevalence of Alzheimer's disease, introduction of novel disease modifying drugs, growing healthcare expenditure and rising awareness about the condition. However, high costs associated with drug R&D and failure of late stage clinical trials can hamper the market growth. Developing regions with large elderly populations an offer significant growth opportunities. Technological advancements in early diagnosis and advancements in understanding the disease pathology can also offer new opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global Alzheimer's drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Alzheimer's drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include AbbVie, Inc., Teva Pharmaceuticals Ltd., Eisai Co., Ltd., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Novartis AG, Zydus Lifesciences Ltd (CADILA), Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd, Aurobindo Pharma Ltd, Amneal Pharmaceuticals Inc., Macleods Pharmaceuticals Ltd., Viatris Inc., Lupin Ltd, Cipla Ltd., Torrent Pharmaceuticals Ltd., Unichem laboratories ltd, Lannett Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global Alzheimer's drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Alzheimer's drugs market

Detailed Segmentation-

• By Drug Class
  • Cholinesterase Inhibitors
  • Donepezil
  • Rivastigmine
  • Galantamine
  • NMDA Receptor Antagonist
  • Memantine
  • Combination Therapy
  • Donepezil and Memantine
  • Pipeline Drugs
  • Aducanumab
  • Lecanemab
  • Donanemab
• By Route of Administration
  • Oral
  • Parenteral
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie, Inc.
  • Teva Pharmaceuticals Ltd.
  • Eisai Co., Ltd.
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  • Novartis AG
  • Zydus Lifesciences Ltd (CADILA)
  • Sun Pharmaceutical Industries Ltd.
  • Reddy's Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd.
  • Viatris Inc.
  • Lupin Ltd
  • Cipla Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Unichem laboratories ltd
  • Lannett Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Alzheimer's Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Alzheimer's Drugs Market, By Drug Class, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cholinesterase Inhibitors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Donepezil
• Rivastigmine
• Galantamine
• NMDA Receptor Antagonist
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Memantine
• Combination Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Donepezil and Memantine
• Pipeline Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Aducanumab
• Lecanemab
• Donanemab

6. Global Alzheimer's Drugs Market, By Route of Administration, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Alzheimer's Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Alzheimer's Drugs Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisai Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zydus Lifesciences Ltd (CADILA)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dr. Reddy's Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd.
  • Viatris Inc.
  • Lupin Ltd
  • Cipla Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Unichem laboratories ltd
  • Lannett Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact